Clin2
NCT07066605Possibly a fitRecruiting

Dexmedetomidine for agitation during breathing tube removal

Dexmedetomidine

Treatments studied

Part of Brain & nervous system, Lungs & breathing, Mental health clinical trials.

This trial tests whether a sedative called dexmedetomidine can reduce agitation in ICU patients when they are being weaned off a breathing tube. If you experience restlessness or agitation during the weaning process, this medication might help you stay calm.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
62 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older and in the ICU.
  • You have been on a breathing machine for at least 24 hours, and for at least 4 days but not more than 2 weeks.
  • Your doctor says you are ready to start weaning from the breathing machine.
  • During the weaning trial, you have an agitation score of +1 or higher on the Richmond Agitation-Sedation Scale (RASS).
  • You are not allergic to dexmedetomidine.
  • You do not have a very slow heart rate (below 50 beats per minute) or low blood pressure (mean arterial pressure below 60 mmHg).
  • You do not have a brain or nerve condition that affects your awareness.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07377981Not yet recruiting· Phase 4
Combination sedative for delirium in ICU patients on breathing support

This trial tests whether combining two sedative medications, esketamine and dexmedetomidine, is safer and more effective than using dexmedetomidine alone for treating hyperactive delirium in ICU patients who need breathing support. If you or a loved one are experiencing severe confusion and agitation while on a breathing machine, this study may offer a new treatment option.

Nanjing, Jiangsu
NCT06468436Not yet recruiting
Calming medicines for ICU patients on a breathing machine

This study tests a combination of two medicines (dexmedetomidine and esketamine) to help ICU patients who are on a breathing machine feel calm and have less pain. The goal is to find a safe and effective way to keep patients comfortable while they recover.

Beijing, Beijing Municipality
NCT06259565Recruiting· Phase 3
Breathing mask sedation trial for agitated adults

This trial tests whether adding a sedative called dexmedetomidine to non-invasive ventilation (a breathing mask) helps adults who are agitated or uncomfortable while on the mask. It aims to improve comfort and avoid the need for a breathing tube.

Surrey, British Columbia
NCT06620393Not yet recruiting· Phase 2/Phase 3
Dexmedetomidine for reducing agitation after severe brain injury

This study tests whether a drug called dexmedetomidine (a sedative) can help calm patients with severe brain injury who are on a breathing machine in the intensive care unit. If you or your loved one is in this situation, this treatment might reduce agitation and improve recovery.

NCT07480304Enrolling by invitation
Dexmedetomidine mist for stable breathing tube placement

This trial tests if a medication called dexmedetomidine (given as a mist through a nebulizer) can help keep your heart rate and blood pressure steady when a breathing tube is placed for surgery. It may be an option for people having planned surgery who want a smoother experience.

Karachi, Sindh
NCT06251375Not yet recruiting· Phase 4
Early sedation for older patients on breathing machines

This study tests an early sedation medicine called dexmedetomidine in patients 65 and older who need a breathing tube. It may help reduce confusion and time on the machine compared to usual care.

Toronto, Ontario

Hear when a new Dexmedetomidine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.